Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (DSM-5) fifth. Philadelphia: American Psychiatric Publishing，; 2013.
   Google Scholar
• Rodrigues PA, Zaninotto AL, Neville IS, et al. Transcranial magnetic stimulation for the treatment of anxiety disorder. NDT. 2019;Volume 15:2743–2761. doi: 10.2147/NDT.S201407
   Google Scholar
• World Health Organization. Depression and other common mental disorders: global health estimates. Switzerland: World Health Organisation; 2017.
   Google Scholar
• Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch gen psychiatry. 2005;62(6):593–602. doi: 10.1001/archpsyc.62.6.593
   PubMed Web of Science ®Google Scholar
• Kasper S. Anxiety disorders: under-diagnosed and insufficiently treated. Int J Psychiatry Clin Pract. 2006;10(sup1):3–9. doi: 10.1080/13651500600552297
   PubMed Web of Science ®Google Scholar
• Bruce SE, Yonkers KA, Otto MW, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. AJP. 2005;162(6):1179–1187. doi: 10.1176/appi.ajp.162.6.1179
   Google Scholar
• Kroenke K, Spitzer RL, Williams JBW, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann internal med. 2007;146(5):317–325. doi: 10.7326/0003-4819-146-5-200703060-00004
   PubMed Web of Science ®Google Scholar
• Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2)93–107. doi: 10.31887/DCNS.2017.19.2/bbandelow
   PubMed Web of Science ®Google Scholar
• Wang ZD, Wang YM, Li K, et al. The comparison of the wisdom view in Chinese and Western cultures. Current Psychol. 2022;41(11):8032–8043. doi: 10.1007/s12144-020-01226-w
   PubMed Web of Science ®Google Scholar
• Peng K, Nisbett RE. Culture, dialectics, and reasoning about contradiction. American Psychologist. 1999;54(9):741. doi: 10.1037/0003-066X.54.9.741
   Web of Science ®Google Scholar
• Jiang Z, Wang J, Yu X, et al. Comparative efficacy and safety of traditional Chinese patent medicine for anxiety disorders in children or adolescence: a protocol for systematic review and network meta-analysis. Medicine. 2020;99(39):e22274. doi: 10.1097/MD.0000000000022274
   PubMed Web of Science ®Google Scholar
• Brandes M, Bienvenu OJ. Personality and anxiety disorders. Curr Psychiatry Rep. 2006;8(4):263–269. doi: 10.1007/s11920-006-0061-8
   PubMedGoogle Scholar
• Engin E, Benham RS, Rudolph U. An emerging circuit pharmacology of GABAA receptors. Trends Pharmacol Sci. 2018;39(8):710–732. doi: 10.1016/j.tips.2018.04.003
   PubMed Web of Science ®Google Scholar
• LeDoux JE, Cicchetti P, Xagoraris A, et al. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci. 1990;10(4):1062–1069. doi: 10.1523/JNEUROSCI.10-04-01062.1990
   PubMed Web of Science ®Google Scholar
• Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci. 1992;15(1):353–375. doi: 10.1146/annurev.ne.15.030192.002033
   PubMed Web of Science ®Google Scholar
• Shalev AY, Ragel-Fuchs Y, Pitman RK. Conditioned fear and psychological trauma. Biological Psychiatry. 1992;31(9):863–865. doi: 10.1016/0006-3223(92)90113-E
   PubMed Web of Science ®Google Scholar
• Olivier B. Serotonin: a never-ending story. Eur J Pharmacol. 2015;753:2–18. doi: 10.1016/j.ejphar.2014.10.031
   PubMed Web of Science ®Google Scholar
• LI M, YE T, QI D, et al. Research status of clinical trials of drugs and interventions for anxiety disorders. Chinese Gen Pract. 2021;24(11):1418.
   Google Scholar
• Olivier JDA, Olivier B. Translational studies in the complex role of neurotransmitter systems in anxiety and anxiety disorders. Anxiety Disorders: Rethinking And Understand Recent Discov. 2020;1191:121–140.
   Google Scholar
• De Vries YA, De Jonge P, van den Heuvel E, et al. Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression. Br J Psychiatry. 2016;208(6):515–521. doi: 10.1192/bjp.bp.115.173450
   PubMed Web of Science ®Google Scholar
• Nagata T, Suzuki F, Teo AR. Generalized social anxiety disorder: a still‐neglected anxiety disorder 3 decades since Liebowitz’s review. Psychiatry Clin Neurosci. 2015;69(12):724–740. doi: 10.1111/pcn.12327
   PubMed Web of Science ®Google Scholar
• Szuhany KL, Simon NM. Anxiety Disorders: A Review. JAMA. 2022;328(24):2431–2445.
   PubMed Web of Science ®Google Scholar
• Hirschtritt ME, Olfson M, Kroenke K. Balancing the risks and benefits of benzodiazepines. JAMA. 2021;325(4):347–348. doi: 10.1001/jama.2020.22106
   PubMed Web of Science ®Google Scholar
• Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1–3):3–33. doi: 10.1016/S0014-2999(03)01272-X
   PubMed Web of Science ®Google Scholar
• Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open. 2019;2(1):e187399. doi: 10.1001/jamanetworkopen.2018.7399
   PubMed Web of Science ®Google Scholar
• Tibrewal P, Haeusler C, Kanigere MK, et al. Are the benefits of benzodiazepines for anxiety disorders underestimated and their risks overestimated? Aust NZJ Psychiatry. 2021;55(11):1109–1110. doi: 10.1177/00048674211013089
   PubMed Web of Science ®Google Scholar
• Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393(10173):768–777. doi: 10.1016/S0140-6736(18)31793-8
   PubMed Web of Science ®Google Scholar
• Gale C, Glue P, Guaiana G, et al. Influence of covariates on heterogeneity in Hamilton anxiety scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: systematic review and meta-analysis. J Psychopharmacol. 2019;33(5):543–547. doi: 10.1177/0269881118822146
   PubMed Web of Science ®Google Scholar
• Food US. Drug Administration. FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class. Drug Safety and Availability. [cited 2020 Sep 23]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
   Google Scholar
• Stein MB, Craske MG. Treating anxiety in 2017: optimizing care to improve outcomes. JAMA. 2017;318(3):235–236. doi: 10.1001/jama.2017.6996
   PubMed Web of Science ®Google Scholar
• Bandelow B, Reitt M, Röver C, et al. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol. 2015;30(4):183–192. doi: 10.1097/YIC.0000000000000078
   PubMed Web of Science ®Google Scholar
• Modigh K. Antidepressant drugs in anxiety disorders[J]. Acta Psychiatr Scand. 1987;76(S335):57–71. doi: 10.1111/j.1600-0447.1987.tb07749.x
   Google Scholar
• Thanacoody HKR, Thomas SHL. Tricyclic antidepressant poisoning: cardiovascular toxicity[J]. Toxicological Reviews. 2005;24(3):205–214. doi: 10.2165/00139709-200524030-00013
   PubMedGoogle Scholar
• Baldwin DS, den Boer JA, Lyndon G, et al. Efficacy and safety of pregabalin in generalised anxiety disorder: a critical review of the literature. J Psychopharmacol. 2015;29(10):1047–1060. doi: 10.1177/0269881115598411
   PubMed Web of Science ®Google Scholar
• Frampton JE. Pregabalin: a review of its use in adults with generalized anxiety disorder. CNS Drugs. 2014;28(9):835–854. doi: 10.1007/s40263-014-0192-0
   PubMed Web of Science ®Google Scholar
• Greenblatt HK, Greenblatt DJ. Gabapentin and pregabalin for the treatment of anxiety disorders. Clin Pharmacol Drug Dev. 2018;7(3):228–232. doi: 10.1002/cpdd.446
   PubMed Web of Science ®Google Scholar
• Olivares JM, Álvarez E, Carrasco JL, et al. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms. Int Clin Psychopharmacol. 2015;30(5):265–271. doi: 10.1097/YIC.0000000000000087
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Ajel K, Masdrakis VG, et al. Pregabalin for the treatment of generalized anxiety disorder: an update. Neuropsychiatr Dis Treat. 2013;883–892. doi: 10.2147/NDT.S36453
   PubMedGoogle Scholar
• Liu L, Liu C, Wang Y, et al. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol. 2015;13(4):481–493. doi: 10.2174/1570159X1304150831122734
   PubMed Web of Science ®Google Scholar
• Liu PL, Song AR, Dong CD, et al. Network pharmacology study on the mechanism of the herb pair of prepared rehmannia root-Chinese arborvitae kernel for anxiety disorders. Ann Palliat Med. 2021;10(3):3313–3327. doi: 10.21037/apm-21-531
   PubMed Web of Science ®Google Scholar
• Shahrajabian MH, Sun W, Soleymani A, et al. Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses. Phytotherapy Research. 2021;35(3):1237–1247. doi: 10.1002/ptr.6888
   PubMed Web of Science ®Google Scholar
• Hou L. Internet pharmacology analysis of mechanism of Sini Powder in intervening anxiety disorder. Chin Tradit Herbal Drugs. 2019:5154–5161.
   Google Scholar
• Koster EHW, Fox E, MacLeod C. Introduction to the special section on cognitive bias modification in emotional disorders. J Abnorm Psychol. 2009;118(1):1. doi: 10.1037/a0014379
   PubMed Web of Science ®Google Scholar
• Ren Z, Lai L, Yu X, et al. Meta-analysis on CBM for anxiety disorder: effect sizes, moderators and mediation. Adv Methods Pract Psychol Sci. 2016;24(11):1690. doi: 10.3724/SP.J.1042.2016.01690
   Google Scholar
• Eldar S, Ricon T, Bar-Haim Y. Plasticity in attention: implications for stress response in children. Behav Res Ther. 2008;46(4):450–461. doi: 10.1016/j.brat.2008.01.012
   PubMed Web of Science ®Google Scholar
• MacLeod C, Rutherford E, Campbell L, et al. Selective attention and emotional vulnerability: assessing the causal basis of their association through the experimental manipulation of attentional bias. J Abnorm Psychol. 2002;111(1):107. doi: 10.1037/0021-843X.111.1.107
   PubMed Web of Science ®Google Scholar
• Wilson EJ, MacLeod C, Mathews A, et al. The causal role of interpretive bias in anxiety reactivity. J Abnorm Psychol. 2006;115(1):103. doi: 10.1037/0021-843X.115.1.103
   PubMed Web of Science ®Google Scholar
• MacLeod C, Mathews A. Cognitive bias modification approaches to anxiety. Annu Rev Clin Psychol. 2012;8(1):189–217. doi: 10.1146/annurev-clinpsy-032511-143052
   PubMedGoogle Scholar
• Fodor LA, Georgescu R, Cuijpers P, et al. Efficacy of cognitive bias modification interventions in anxiety and depressive disorders: a systematic review and network meta-analysis. The Lancet Psychiatry. 2020;7(6):506–514. doi: 10.1016/S2215-0366(20)30130-9
   PubMed Web of Science ®Google Scholar
• Zhang F, Cai W, Mao X, et al. Antianxiety effect and mechanisms of cognitive bias modification. Chin J Behav Med Brain Sci. 2019;28(12):1149–1152.
   Google Scholar
• Linetzky M, Pergamin‐Hight L, Pine DS, et al. Quantitative evaluation of the clinical efficacy of attention bias modification treatment for anxiety disorders. Depress Anxiety. 2015;32(6):383–391. doi: 10.1002/da.22344
   PubMed Web of Science ®Google Scholar
• Rozenman M, Gonzalez A, Logan C, et al. Cognitive bias modification for threat interpretations: impact on anxiety symptoms and stress reactivity. Depress Anxiety. 2020;37(5):438–448. doi: 10.1002/da.23018
   PubMed Web of Science ®Google Scholar
• van Loenen I, Scholten W, Muntingh A, et al. The effectiveness of virtual reality exposure – based cognitive behavioral therapy for severe anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: meta-analysis. J Med Internet Res. 2022;24(2):e26736. doi: 10.2196/26736
   PubMed Web of Science ®Google Scholar
• Pelissolo A, Abou Kassm S, Delhay L. Therapeutic strategies for social anxiety disorder: where are we now? Expert Rev Neurotherapeutics. 2019;19(12):1179–1189. doi: 10.1080/14737175.2019.1666713
   PubMed Web of Science ®Google Scholar
• Smits JAJ, Julian K, Rosenfield D, et al. Threat reappraisal as a mediator of symptom change in cognitive-behavioral treatment of anxiety disorders: a systematic review. J Consult Clin Psychol. 2012;80(4):624. doi: 10.1037/a0028957
   PubMed Web of Science ®Google Scholar
• Carpenter JK, Andrews LA, Witcraft SM, et al. Cognitive behavioral therapy for anxiety and related disorders: a meta‐analysis of randomized placebo‐controlled trials. Depress Anxiety. 2018;35(6):502–514. doi: 10.1002/da.22728
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang Y, Furukawa TA, et al. Different types and acceptability of psychotherapies for acute anxiety disorders in children and adolescents: a network meta-analysis. JAMA Psychiatry. 2019;76(1):41–50. doi: 10.1001/jamapsychiatry.2018.3070
   PubMed Web of Science ®Google Scholar
• Rapee RM, Schniering CA, Hudson JL. Anxiety disorders during childhood and adolescence: origins and treatment. Annu Rev Clin Psychol. 2009;5(1):311–341. doi: 10.1146/annurev.clinpsy.032408.153628
   PubMedGoogle Scholar
• Kabat-Zinn J. Wherever you go, there you are: mindfulness meditation in everyday life. London: Hachette UK; 2023.
   Google Scholar
• Haller H, Breilmann P, Schröter M, et al. A systematic review and meta-analysis of acceptance-and mindfulness-based interventions for DSM-5 anxiety disorders. Sci Rep. 2021;11(1):20385. doi: 10.1038/s41598-021-99882-w
   PubMed Web of Science ®Google Scholar
• Hoge EA, Bui E, Mete M, et al. Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2023;80(1):13–21. doi: 10.1001/jamapsychiatry.2022.3679
   PubMed Web of Science ®Google Scholar
• Taylor JH, Jakubovski E, Bloch MH. Predictors of anxiety recurrence in the coordinated anxiety learning and management (CALM) trial. J Psychiatr Res. 2015;65:154–165. doi: 10.1016/j.jpsychires.2015.03.020
   PubMed Web of Science ®Google Scholar
• Szkodny LE, Newman MG, Goldfried MR. Clinical experiences in conducting empirically supported treatments for generalized anxiety disorder. Behav Ther. 2014;45(1):7–20. doi: 10.1016/j.beth.2013.09.009
   PubMed Web of Science ®Google Scholar
• Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch gen psychiatry. 2001;58(1):55–61. doi: 10.1001/archpsyc.58.1.55
   PubMed Web of Science ®Google Scholar
• Weisberg RB, Gonsalves MA, Ramadurai R, et al. Development of a cognitive bias modification intervention for anxiety disorders in primary care. British J Clinic Psychol. 2022;61(S1):73–92. doi: 10.1111/bjc.12281
   PubMedGoogle Scholar
• National Institute for Health and Clinical Excellence (NICE). Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. London: The British Psychological Society and The Royal College of Psychiatrists; 2011 [cited 2015 12 Apr] Available from: http://www.nice.org.uk
   Google Scholar
• National Institute for Health and Clinical Excellence (NICE). Social anxiety disorder: recognition, assessment and treatment (full guideline). London: The British Psychological Society and The Royal College of Psychiatrists; 2013 [cited 2015 Apr 12]. Available from: http://www.nice.org.uk
   Google Scholar
• Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753–2766. doi: 10.1056/NEJMoa0804633
   PubMed Web of Science ®Google Scholar
• Mogoaşe C, David D, Koster EHW. Clinical efficacy of attentional bias modification procedures: an updated meta‐analysis. J Clin Psychol. 2014;70(12):1133–1157. doi: 10.1002/jclp.22081
   PubMed Web of Science ®Google Scholar
• Heeren A, Mogoașe C, Philippot P, et al. Attention bias modification for social anxiety: a systematic review and meta-analysis. Clin Psychol Rev. 2015;40:76–90. doi: 10.1016/j.cpr.2015.06.001
   PubMed Web of Science ®Google Scholar
• Hayes S, Hirsch CR, Krebs G, et al. The effects of modifying interpretation bias on worry in generalized anxiety disorder. Behav Res Ther. 2010;48(3):171–178. doi: 10.1016/j.brat.2009.10.006
   PubMed Web of Science ®Google Scholar
• Salemink E, Kindt M, Rienties H, et al. Internet-based cognitive bias modification of interpretations in patients with anxiety disorders: a randomised controlled trial. J Behav Ther Exp Psychiatry. 2014;45(1):186–195. doi: 10.1016/j.jbtep.2013.10.005
   PubMed Web of Science ®Google Scholar
• Vrijsen JN, Fischer VS, Müller BW, et al. Cognitive bias modification as an add-on treatment in clinical depression: results from a placebo-controlled, single-blinded randomized control trial. J Affect Disorders. 2018;238:342–350. doi: 10.1016/j.jad.2018.06.025
   PubMed Web of Science ®Google Scholar
• Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res. 2001;125(1–2):141–149. doi: 10.1016/S0166-4328(01)00291-1
   PubMed Web of Science ®Google Scholar
• Gutiérrez-García AG, Contreras CM. New Insights Into Anxiety Disorders London: InTech. 2013;21–37.
   Google Scholar
• Lister RG. Ethologically-based animal models of anxiety disorders. Pharmacol Ther. 1990;46(3):321–340. doi: 10.1016/0163-7258(90)90021-S
   PubMed Web of Science ®Google Scholar
• Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56(2):267. doi: 10.1037/0022-3514.56.2.267
   PubMed Web of Science ®Google Scholar
• Updegraff JA, Taylor SE. From vulnerability to growth: positive and negative effects of stressful life events[M]//Loss and trauma. London; New York: Routledge. 2021:3–28.
   Google Scholar
• Kendrick T, Pilling S. Common mental health disorders – identification and pathways to care: NICE clinical guideline. Br J Gen Pract. 2012;62(594):47–49. doi: 10.3399/bjgp12X616481
   PubMed Web of Science ®Google Scholar
• Bystritsky A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006;11(9):805–814. doi: 10.1038/sj.mp.4001852
   PubMed Web of Science ®Google Scholar
• Nisbett RE, Miyamoto Y. The influence of culture: holistic versus analytic perception. Trends Cogn Sci. 2005;9(10):467–473. doi: 10.1016/j.tics.2005.08.004
   PubMed Web of Science ®Google Scholar